Non-Fiction Books:

Health Technology Assessment, Courts and the Right to Healthcare

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Paperback / softback
$92.00
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 2-3 weeks
Free Delivery with Primate
Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

Afterpay is available on orders $100 to $2000 Learn more

6 weekly interest-free payments of $15.33 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 6-18 June using International Courier

Description

Both developing and developed countries face an increasing mismatch between what patients expect to receive from healthcare and what the public healthcare systems can afford to provide. Where there has been a growing recognition of the entitlement to receive healthcare, the frustrated expectations with regards to the level of provision has led to lawsuits challenging the denial of funding for health treatments by public health systems. This book analyses the impact of courts and litigation on the way health systems set priorities and make rationing decisions. In particular, it focuses on how the judicial protection of the right to healthcare can impact the institutionalization, functioning and centrality of Health Technology Assessment (HTA) for decisions about the funding of treatment. Based on the case study of three jurisdictions – Brazil, Colombia, and England – it shows that courts can be a key driver for the institutionalization of HTA. These case studies show the paradoxes of judicial control, which can promote accountability and impair it, demand administrative competence and undermine bureaucratic capacities. The case studies offer a nuanced and evidence-informed understanding of these paradoxes in the context of health care by showing how the judicial control of priority-setting decisions in health care can be used to require and control an explicit scheme for health technology assessment, but can also limit and circumvent it. It will be essential for those researching Medical Law and Healthcare Policy, Human Rights Law, and Social Rights.

Author Biography:

Daniel Wei Liang Wang is Associate Professor at Fundação Getúlio Vargas (FGV) School of Law. Before joining FGV, he was a Lecturer (Assistant Professor) in Health and Human Rights at Queen Mary University of London and a Law Fellow at the London School of Economics, where he taught Human Rights Law. Daniel holds a PhD in Law (LSE), an MSc in Philosophy and Public Policies (LSE), a Master in Law (University of São Paulo), a BA in Social Sciences (University of São Paulo) and a BA in Law (University of São Paulo). He was a member of the National Health Service (NHS) Central London Research Ethics Committee (2017-2019).
Release date NZ
September 25th, 2023
Author
Audience
  • Tertiary Education (US: College)
Illustrations
6 Tables, black and white; 9 Line drawings, black and white; 9 Illustrations, black and white
Pages
202
ISBN-13
9781032184913
Product ID
37860975

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

Filed under...